The U.S. Food and Drug Administration (FDA) granted an extra clearance to the Unity Subcutaneous Delivery System for…
Articles by Iqra Mumal, MSc
The ATS Foundation Research Program and Pulmonary Hypertension Association have announced the 2019 recipients of their partner grants, totaling…
Aria CV‘s medical device for treating pulmonary hypertension (PH) has been given a Breakthrough Device designation by…
A new generic version of Actelion’s Tracleer (bosentan), developed by Alembic Pharmaceuticals, has been approved by the U.S. Food and…
Measuring the levels of the N‐terminal pro B-type natriuretic peptide (NT-proBNP) — a validated and widely accepted prognostic marker of…
Acceleron Pharma and Fulcrum Therapeutics are working together to discover small molecules that can be used to treat…
Use of Bellerophon Therapeutics’s INOpulse device led to clinically meaningful improvements in people with pulmonary hypertension associated…
Iconovo has signed a Letter of Understanding with CrystecPharma to collaborate on the design and development of new…
Owlstone Medical announced that it has introduced a new ReCIVA Breath Sampler and CASPER Portable Air Supply, designed to support…
Targeting the pro-inflammatory TGF-β signaling pathway in specific cells of the pulmonary arteries — those with high levels of a…
A Phase 2 clinical trial for levosimendan, a potential treatment for pulmonary hypertension (PH) and heart failure with…
An estimated right ventricular systolic pressure (eRVSP) — a measure of the pressure inside the artery that supplies blood to…